The ABC of clinical and experimental adjuvants-A brief overview

被引:107
作者
Brunner, Richard [1 ]
Jensen-Jarolim, Erika [1 ]
Pali-Schoell, Isabella [1 ]
机构
[1] Med Univ Vienna, IPP Dept Pathophysiol, Vienna, Austria
基金
奥地利科学基金会;
关键词
Adjuvant; Immune response; Aluminum; MF59; Monophosphoryl lipid A; Poly-lactid-co-glycolid acid; Virosomes; Freund's adjuvant; Nanoparticles; Cholera toxin B; Flagellin; MONOPHOSPHORYL-LIPID-A; TOLL-LIKE RECEPTOR; T-CELL RESPONSES; TOXIN B-SUBUNIT; HUMORAL IMMUNE-RESPONSES; INFLUENZA VACCINE; DENDRITIC CELLS; ORAL IMMUNIZATION; ANTIBODY-RESPONSES; ADAPTIVE IMMUNITY;
D O I
10.1016/j.imlet.2009.10.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adjuvants are compounds that can increase and/or modulate the intrinsic immunogenicity of an antigen and elicit strong and long lasting immune responses. During the last 80 years many adjuvants have been used in experimental settings, but due to various shortcomings of most of them only aluminum compounds made it into regular clinical usage. However, during the last years promising candidates have arisen that may finally adjunct or displace aluminum substances as main adjuvant. This review summarizes information on adjuvants currently used in clinical as well as in experimental settings. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 110 条
[1]   Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines;: immunity, pathology and protection [J].
Agger, Else Marie ;
Cassidy, Joseph P. ;
Brady, Joseph ;
Korsholm, Karen S. ;
Vingsbo-Lundberg, Carina ;
Andersen, Peter .
IMMUNOLOGY, 2008, 124 (02) :175-185
[2]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[3]   Design and selection of vaccine adjuvants: animal models and human trials [J].
Alving, CR .
VACCINE, 2002, 20 :S56-S64
[4]   Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations [J].
Atmar, Robert L. ;
Keitel, Wendy A. ;
Patel, Shital M. ;
Katz, Jacqueline M. ;
She, Dewei ;
El Sahly, Hana ;
Pompey, Justine ;
Cate, Thomas R. ;
Couch, Robert B. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (09) :1135-1142
[5]   Safety evaluation of monophosphoryl lipid a (MPL): An immunostimulatory adjuvant [J].
Baldrick, P ;
Richardson, D ;
Elliott, G ;
Wheeler, AW .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2002, 35 (03) :398-413
[6]   Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid a (MPL®) for the treatment of grass pollen allergy [J].
Baldrick, P ;
Richardson, D ;
Wheeler, AW ;
Woroniecki, SR .
JOURNAL OF APPLIED TOXICOLOGY, 2004, 24 (04) :261-268
[7]   Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines [J].
Baldridge, JR ;
Crane, RT .
METHODS, 1999, 19 (01) :103-107
[8]   MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults [J].
Banzhoff, Angelika ;
Gasparini, Roberto ;
Laghi-Pasini, Franco ;
Staniscia, Tommaso ;
Durando, Paolo ;
Montomoli, Emanuele ;
Capecchi, Pamela ;
di Giovanni, Pamela ;
Sticchi, Laura ;
Gentile, Chiara ;
Hilbert, Anke ;
Brauer, Volker ;
Tilman, Sandrine ;
Podda, Audino .
PLOS ONE, 2009, 4 (02)
[9]   Direct Stimulation of tlr5+/+ CD11c+ Cells Is Necessary for the Adjuvant Activity of Flagellin [J].
Bates, John T. ;
Uematsu, Satoshi ;
Akira, Shizuo ;
Mizel, Steven B. .
JOURNAL OF IMMUNOLOGY, 2009, 182 (12) :7539-7547
[10]   Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (ARILVAX™ and YF-VAX®) in healthy infants and children in Peru [J].
Belmusto-Worn, VE ;
Sanchez, JL ;
McCarthy, K ;
Nichols, R ;
Bautista, CT ;
Magill, AJ ;
Pastor-Cauna, G ;
Echevarria, C ;
Laguna-Torres, VA ;
Samame, BK ;
Baldeon, ME ;
Burans, JP ;
Olson, JG ;
Bedford, P ;
Kitchener, S ;
Monath, TP .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (02) :189-197